Dr. Natalia Lattanzio, MD

Dr. Lattanzio practices at Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System.

Dr. Lattanzio's NPI, 1316409972, was assigned on April 3, 2019. Dr. Lattanzio graduated from St. George's University School of Medicine in 2019. Dr. Lattanzio holds Florida license ME154507.

Dr. Lattanzio's primary practice is Sarasota Memorial Hospital - Sarasota Campus, at 1700 S Tamiami Trl, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 917-9000.

Dr. Lattanzio's primary practice is Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System. Dr. Lattanzio is also affiliated with Sarasota Memorial Hospital-Venice. The medical group on file is First Physicians Group of Sarasota. Dmand AI also links Dr. Lattanzio to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lattanzio practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lattanzio's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lattanzio is board certified in internal medicine by the American Board of Internal Medicine. Dr. Lattanzio is licensed in Florida.

Dmand AI lists acute diabetes, acute respiratory failure, acute stomach ulcer, anemia, atherosclerosis, cardiac arrhythmia, cellulitis and chest pain among the conditions Dr. Lattanzio treats.

CMS data shows 1,023 Medicare services from Dr. Lattanzio across 6 procedure codes in 2024, for 471 Medicare patients. Medicare paid $84,264 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 471 Medicare patients who saw Dr. Lattanzio in 2024. The largest group is 75 to 84, with 185 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lattanzio's median patient age at 77, with 48% women.

In 2024, Dr. Lattanzio wrote 305 Medicare Part D claims for 145 patients. 84% of them were for generic drugs. CMS names the drug for 113 of them, across 8 drugs with 11 or more claims each, at $14,240 in total drug cost. In 2023, CMS named 104 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Lattanzio for performance year 2024, reported as part of a group. Dr. Lattanzio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Lattanzio, published from 2019 to 2021. 2020 was the busiest year, with 4. Dr. Lattanzio has published most often in Cureus. Dr. Lattanzio's most frequent co-authors are Christian Josue Lorenzo, MD, Ricardo Jose Villasmil, MD and Qassem Khaled Abdelal, MD.

CMS Open Payments shows 2 general payments to Dr. Lattanzio from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $125.

Dr. Lattanzio graduated from St. George's University School of Medicine in 2019.

Dr. Lattanzio is in network with 2 carriers, including Aetna and CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.